Introduction Idiopathic pulmonary fibrosis (IPF), a fatal lung disease of unknown origin, is
characterized by chronic and progressive fibrosing interstitial pneumonia which …

Background: Interstitial lung disease (ILD) encompasses a diverse group of disorders
characterized by chronic inflammation and fibrosis of the pulmonary interstitium. Three ILDs …

Objective This study aims to explore the relevance of anoikis in idiopathic pulmonary fibrosis
(IPF) and identify associated biomarkers and signaling pathways. Method Unsupervised …

Background Idiopathic pulmonary fibrosis (IPF) is associated with an increased risk for lung
cancer, but the underlying mechanisms driving malignant transformation remain largely …

Background Epidemiological evidence has indicated the occurrence of idiopathic pulmonary
fibrosis (IPF) with coexisting lung cancer is not a coincidence. The pathogenic mechanisms …

Background There is still a lack of specific indicators to diagnose idiopathic pulmonary
fibrosis (IPF). And the role of immune responses in IPF is elusive. In this study, we aimed to …

Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with a significant
unmet medical need. Development of transformational therapies for IPF is challenging in …

Background: Most patients with idiopathic pulmonary fibrosis (IPF) have poor prognosis;
Effective predictive models for these patients are currently lacking. Epithelial–mesenchymal …

Background Idiopathic pulmonary fibrosis (IPF) is the most common type of fatal interstitial
lung disease and IPF patients usually have a poor prognosis. Biomarkers that can predict …

Idiopathic pulmonary fibrosis (IPF) is a severe fibrotic lung disease characterized by
irreversible scarring of the lung parenchyma leading to dyspnea, progressive decline in lung …